CHRU Montpellier
Montpellier, France
NCT Number: NCT01235624
Identify new genes responsible for autosomal dominant retinitis pigmentosa (ADRP), one of the most common causes of hereditary diseases of the retina, and thus better understand the mechanisms involved of the disease."
Looking for future studies?
Notify Me5 year–80 year
All sexes
Interventional
Not applicable
Montpellier, France
Two hundred and fifty samples from unrelated patients, from which 150 were provided by the national reference center of rare disease in Montpellier and 100 recruited in the 9 participating centers over a period of two years."To identify the missing genes, we proceed in two steps. A first step in selecting families negative for the 8 major genes genes, by systematic sequencing of exons most frequently involved. A second step in finding new loci / genes by locus exclusion using microsatellite markers and SNP genotyping.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: for 5 years
University Hospital, Montpellier
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04123626
Autosomal Dominant Retinitis Pigmentosa, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Aurora, Colorado, United States
View Trial DetailsNCT01347047
Amyloidosis, Disease Attributes
Buenos Aires, Argentina
View Trial DetailsNCT00339157
Arthritis, Arthritis, Juvenile
Bordeaux, France
View Trial DetailsNCT02116764
Chronic Disease, Chronic Granulomatous Disease
Bethesda, Maryland, United States
View Trial Details